No profile data available.
Celularity Inc. (CELU) is a healthcare company in the operation equipment industry, based in Florham Park, United States, with about 123 full-time employees.
It reported revenue of $26.55 million for fiscal year 2025, down 51.0% from fiscal year 2024, and net income of -$91.80 million. Its largest business segment, Product, brought in 50% of segment revenue in fiscal year 2025. Its market capitalization was $55.89 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of December 4, 2025.
, a regenerative and cellular medicines company, focuses on addressing aging-related and degenerative diseases. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease.
Celularity reported $26.55 million in revenue for fiscal year 2025, down 51.0% from $54.22 million in fiscal year 2024.
Product, with $13.18 million or 50% of segment revenue in fiscal year 2025. Next: License Royalty and Other (30%) and Service (20%).
$55.89 million as of December 4, 2025.
Listed companies of a similar size in the same industry (operation equipment) include Intuitive Surgical, Inc. (ISRG), Conmed Corporation (CNMD), SS Innovations International, Inc. (SSII), Tela Bio, Inc. (TELA).